Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
-0.20%
N225
-0.22%
AXJO
-0.21%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
104.30M
Dividend Yield
0.00%
P/E Ratio
NaN
EPS
-0.18
Revenue
-
Avg. Volume
-

Recently from Cashu

publisher logo
Cashu

Satellos Bioscience Inc. Showcases Muscle Disease Research at PPMD Conference 2025

3 days ago
publisher logo
Cashu

Satellos Bioscience Inc. Advances SAT-3247 for Promising Duchenne Muscular Dystrophy Treatment

28 days ago
publisher logo
Cashu

Satellos Bioscience Inc. Boosts Investor Relations with $1.6M Warrant Exercise by Bloom Burton

29 days ago

About

What does MSCL.TO do?
Satellos Bioscience, a Toronto-based regenerative medicine company, focuses on developing therapeutics for muscle diseases using its MyoReGenX platform. Its lead program targets Duchenne muscular dystrophy with an oral small molecule drug candidate.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Website
https://satellos.com
Stocks
Health Care
mscl.to
Satellos Bioscience Inc
TO: MSCL.TO
0.00 (0.00%)
0.55
USD
At close at Jun 21, 24:39 UTC
Summary
News
Signals
Benchmarks
Financials